1nHealth at SCOPE2025

Click any of the ads below to read more info about that enrollment campaign.

Vitiligo

This was a very successful study from start to finish, beginning with engaging and colorful ads across Meta’s platforms and reinforced with strong relationships with site staff. teams from the start facilitated great communication and joint decision making.

Toward the end of the campaign we encouraged sites to continue at the same pace as the beginning and to keep momentum for the final patients in the enrollment funnel.

Enrollment projection: November 2024
Enrollment actual: September 2024

Finished two months ahead of original LPI expectations.

Vaping Cessation

This was a wide-reaching study seeking to enroll 230 patients across the United States, Canada, Germany, and the UK. We learned through A/B optimization that Vector images outperformed AI-generated images, abstract visuals, and photos, likely because these images highlighted the relevance to the viewer very quickly. Psychedelic colors and shapes performed well, as they are culturally aligned with the target audience especially in the UK and EU.

Further down the enrollment funnel, individual sites were not updating 1nData with referral statuses. The 1nHealth team implemented weekly site communications regarding best practices, and all missing updates from the system. These changes resulted in improved system updates from site staff across the board.

Eczema

A therapeutics company asked us to recruit patients with moderate-to-severe Atopic Dermatitis across the U.S. and Canada. The patients have weekly clinic visits until Day 22​, and two follow up visits are over the phone. Patients must stay for several hours of observation on dosing visit days.

We A/B tested AI imagery against funny and lighthearted visuals and messaging and found that both performed equally as well but hit two very distinct audiences. To maximize our top-of-funnel results, we ran both ad sets simultaneously and captured the attention of two audiences at once.

We also coordinated closely with site staff to customize top-of-funnel recruitment efforts to match capacity levels which were always in flux. This allowed us to prevent high-quality referrals from slipping through the cracks over the 9-month campaign.

ADHD

We were brought on as the enrollment partner from the very beginning of this study seeking 1,000 participants.

The integration with ObvioGo and 1nData was seemless and allowed for automated updates of referral statuses as the study progressed. This allowed for all team members to have instant updates on study progress towards enrollment.

Through A/B testing, we pivoted to videos, specifically TikTok and Instagram Reels, and they ended up being our best-performing top-of-funnel recruitment assets.

Bipolar Disorder

1nHealth was the third enrollment vendor hired for this study after two previous competitors failed to enroll a single patient.

Our creative and messaging was a big winner. Whether it was video ads or images they were able to consistently drive top-of-funnel volume.

After some time working with the sites and noting which were performing the most efficiently, we optimized our campaign to funnel patients to the best sites. For example, a site in Savannah, GA nearly 10x’d their metro population size when compared to their ICF contribution.

1nHealth: We own enrollment

For clinical trial sponsors who refuse to settle for study delays and inefficiencies, 1nHealth resets the standard. We deliver unparalleled results and fill studies faster than you ever thought possible. 

Ready for a patient recruitment company that owns enrollment?

Fill out the form below and we’ll respond within 1 business day.

424 E Central Blvd. #129 Orlando, FL 32801

Company

©2025 – 1nHealth. All Rights Reserved |  Legal Notice & Terms of Service